Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to determine whether CEP 701 treatment given in sequence with induction chemotherapy increases the proportion of patients with relapsed acute myeloid leukemia (AML) who achieve a second complete remission (CR) or a CR with incomplete platelet recovery (CRp).
Critère d'inclusion
- Relapsed Acute Myeloid Leukaemia (AML) expressing FLT-3 activating mutations